Literature DB >> 18046596

Relation of left ventricular hypertrophy to microalbuminuria and C-reactive protein in children and adolescents with essential hypertension.

Farahnak Assadi1.   

Abstract

Microalbuminuria (MA) and C-reactive protein (CRP) levels are predictors of increased risk for left ventricular hypertrophy (LVH). Whether the strength of association between CRP and LVH is comparable to that of MA in hypertensive children is unknown. CRP and MA were measured in 64 children and adolescents with essential hypertension (HTN). In the entire population, CRP and MA showed positive relations with body mass index (BMI) (r = 0.30, p = 0.04 and r = 0.32, p = 0.04, respectively), systolic blood pressure (SBP) (r = 0.63, p = 0.03 and r = 0.58, p = 0.03, respectively), and LVH (r = 0.86, p < 0.001 and r = 0.81, p < 0.001, respectively). Patients with LVH (n = 23) had significantly higher BMI (p = 0.32), increased SBP (p = 0.031), and higher levels of CRP (p < 0.001) and MA (p < 0.001) compared with those without LVH. Multiple linear regression analysis demonstrated that CRP (r = 2.11, p < 0.001), MA (r = 1.94, p < 0.003), BMI (r = 0.53, p = 0.02), and SBP (r = 0.48, p = 0.04) were significantly associated with LVH. By analysis of covariance, CRP and MA were significantly different between patients who had LVH and those without LVH after adjustment for age, gender, BMI, SBP, SBP index, and diastolic blood pressure (p < 0.001 for the two markers). In conclusion, the strength of association between LVH and CRP is comparable to that of MA in children and adolescents with essential HTN.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18046596     DOI: 10.1007/s00246-007-9153-4

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  33 in total

1.  Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation.

Authors:  W F Keane; G Eknoyan
Journal:  Am J Kidney Dis       Date:  1999-05       Impact factor: 8.860

2.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

3.  Microalbuminuria as a marker of preclinical diastolic dysfunction in never-treated essential hypertensives.

Authors:  A M Grandi; R Santillo; A Bertolini; D Imperiale; R Broggi; S Colombo; E Selva; A Jessula; L Guasti; A Venco
Journal:  Am J Hypertens       Date:  2001-07       Impact factor: 2.689

4.  Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension.

Authors:  Farahnak Assadi
Journal:  Pediatr Cardiol       Date:  2007-02-16       Impact factor: 1.655

5.  Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect.

Authors:  Giancarlo Viberti; Nigel M Wheeldon
Journal:  Circulation       Date:  2002-08-06       Impact factor: 29.690

Review 6.  Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment?

Authors:  Dick de Zeeuw
Journal:  Kidney Int Suppl       Date:  2004-11       Impact factor: 10.545

7.  Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk.

Authors:  G de Simone; R B Devereux; S R Daniels; M J Koren; R A Meyer; J H Laragh
Journal:  J Am Coll Cardiol       Date:  1995-04       Impact factor: 24.094

8.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

Authors:  G de Simone; S R Daniels; R B Devereux; R A Meyer; M J Roman; O de Divitiis; M H Alderman
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

9.  C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease.

Authors:  Erik M Stuveling; Hans L Hillege; Stephan J L Bakker; Folkert W Asselbergs; Paul E de Jong; Reinold O B Gans; Dick de Zeeuw
Journal:  Atherosclerosis       Date:  2004-01       Impact factor: 5.162

10.  Establishing a standard definition for child overweight and obesity worldwide: international survey.

Authors:  T J Cole; M C Bellizzi; K M Flegal; W H Dietz
Journal:  BMJ       Date:  2000-05-06
View more
  17 in total

Review 1.  Diagnosis and treatment of hypertension in children.

Authors:  Empar Lurbe; Julio Álvarez; Josep Redon
Journal:  Curr Hypertens Rep       Date:  2010-12       Impact factor: 5.369

2.  The epidemic of pediatric chronic kidney disease: the danger of skepticism.

Authors:  Farahnak Assadi
Journal:  J Nephropathol       Date:  2012-07-01

Review 3.  Evaluation of hypertension in children.

Authors:  Gaurav Kapur; Rossana Baracco
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

4.  Microalbuminuria in children with primary and white-coat hypertension.

Authors:  Tomáš Seeman; Michael Pohl; Daniela Palyzova; Ulrike John
Journal:  Pediatr Nephrol       Date:  2011-10-05       Impact factor: 3.714

5.  Inflammatory activation in children with primary hypertension.

Authors:  Mieczyslaw Litwin; Jacek Michałkiewicz; Anna Niemirska; Lidia Gackowska; Lidia Gockowska; Izabela Kubiszewska; Aldona Wierzbicka; Zbigniew T Wawer; Roman Janas
Journal:  Pediatr Nephrol       Date:  2010-05-21       Impact factor: 3.714

6.  Allopurinol enhances the blood pressure lowering effect of enalapril in children with hyperuricemic essential hypertension.

Authors:  Farahnak Assadi
Journal:  J Nephrol       Date:  2013-12-13       Impact factor: 3.902

Review 7.  The growing epidemic of hypertension among children and adolescents: a challenging road ahead.

Authors:  Farahnak Assadi
Journal:  Pediatr Cardiol       Date:  2012-05-08       Impact factor: 1.655

Review 8.  Subclinical Organ Damage in Children and Adolescents with Hypertension: Current Guidelines and Beyond.

Authors:  Denise Marcon; Angela Tagetti; Cristiano Fava
Journal:  High Blood Press Cardiovasc Prev       Date:  2019-10-24

Review 9.  Epigenetic modification: a regulatory mechanism in essential hypertension.

Authors:  Mohammed Arif; Sakthivel Sadayappan; Richard C Becker; Lisa J Martin; Elaine M Urbina
Journal:  Hypertens Res       Date:  2019-03-13       Impact factor: 3.872

10.  Left Ventricular Hypertrophy Phenotype in Childhood-Onset Essential Hypertension.

Authors:  Monesha Gupta-Malhotra; Syed Shahrukh Hashmi; Tim Poffenbarger; Karen McNiece-Redwine
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-10-05       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.